Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2b46e05f9bbd846aa4d07ff31a59d82 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 |
filingDate |
2006-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64e82effc534b75128fde4ed10d5ae7a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_712b455ce01194f68195d6f088608d5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03356ada0574f2a3580bc0c8e913dcfa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9169e8479788d1802801b8939ca4773f |
publicationDate |
2007-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2007219172-A1 |
titleOfInvention |
Selective testicular 11beta-HSD inhibitors for the treatment of hypergonadism associated disorders and modulation of fertility |
abstract |
Methods for modulating testosterone levels using selective 11β-HSD1-dehydrogenase, 11β-HSD1-reductase and 11β-HSD2 dehydrogenase modulating compounds are described. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108277170-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103340879-A |
priorityDate |
2005-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |